Rating History for Lexicon Pharmaceuticals (LXRX) by JPMorgan

More Stocks Rated by JPMorgan | Latest Ratings for LXRX
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
1/29/2021 Jessica Fye Upgrade Neutral
(Underweight)		 7.00
(N/A)		 8.06
(2.30)		 -71.46% Details